Horizon Europe👥 Consortium Required (Min. 3 EU Countries)

Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process control → ACHILLES THERAPEUTICS UK LIMITED

Opportunity overview

Recipient: ACHILLES THERAPEUTICS UK LIMITED • Role: associatedpartner • Project: SMARTER • Objective: Autologous immunotherapies have revolutionised cancer treatment providing impressive survival benefits in patients with blood cancers. The next generation of personalised immunot
Pro Feature

Unlock Complete Call Dossier

Read the unredacted funding guidelines, scope, eligibility criteria, and submission instructions.

Upgrade to Pro to Read Full Call →

EU Fund Portal Signals

Is this worth the team's time?

Directional signals based on the call structure, available source text, and deadline pressure. These are not funding guarantees.

Source language: EnglishConfidence: Medium

Competition

4/ 5

Lower Competition

5 means a narrower, more approachable field. 1 means heavy competition.

Application Effort

2/ 5

Manageable

1 is straightforward. 5 means a demanding application with heavier coordination or compliance.

Why competition looks like this

Confidence: Medium
  • The call looks specialized, which can narrow the field of credible applicants.

Why effort looks like this

Confidence: Medium
  • Coordinating a consortium raises the delivery and application burden.
AI Dossier Preview

Unlock Full Feasibility Intelligence & Consultant Analysis

Pro members access complete competitive breakdowns, compliance risk analyses, plain-English translations for foreign-language notices, and tailored submission checklists.

Unlock Pro Intelligence →Instant access • Cancel anytime

Consortium

Likely needed

Co-funding

Not clearly indicated

Documentation

Low

Deadline pressure

Closed

Eligibility scope

Narrow

Technical depth

Low

Eligibility

Awarded

Application deadline

27/06/2022
Deadline expired

Key information

Sector
Other
Country
GB
Funder
European Commission (Horizon Europe)

Official Application Portal

Direct submission URL and issuing body documents are reserved for Pro subscribers.

Unlock Official Portal Link →
Tracked by EU Fund Portal since 21/09/2026
Last checked 21/09/2026

Preparation Checklist

Get a step-by-step preparation checklist tailored to this programme. Available on Pro.

Read the full call text and topic description
Check consortium requirements
Identify consortium partners
Upgrade to Pro to unlock
Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process control → ACHILLES THERAPEUTICS UK LIMITED | EU Fund Portal